References
1. Boiten HJ, van Domburg RT, Valkema R, Zijlstra F, Schinkel AF. Dobutamine stress myocardial perfusion imaging: 8-year outcomes in patients with diabetes mellitus. European Heart Journal-Cardiovascular Imaging. 2016;17(8):871-6.
2. Zellweger MJ, Haaf P, Maraun M, Osterhues HH, Keller U, Müller-Brand J, et al. Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus. International journal of cardiology. 2017;244:37-42.
3. Weinrauch L, D’elia J, Healy R, Gleason R, Takacs F, Libertino J, et al. Asymptomatic coronary artery disease: angiography in diabetic patients before renal transplantation: relation of findings to postoperative survival. Annals of internal medicine. 1978;88(3):346-8.
4. Mitevska IP, Baneva N, Srbinovska E, Stojanovska L, Apostolopoulos V, Bosevski M. Prognostic implications of myocardial perfusion imaging and coronary calcium score in a Macedonian cohort of asymptomatic patients with type 2 diabetes. Diabetes and Vascular Disease Research. 2017;14(4):285-94.
5. Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Molecular Medicine. 2018;24(1):1-12.
6. Naito R, Miyauchi K. Coronary artery disease and type 2 diabetes mellitus current treatment strategies and future perspective. International heart journal. 2017:17-191.
7. Sanchez-Alcoholado L, Castellano-Castillo D, Jordán-Martínez L, Moreno-Indias I, Cardila-Cruz P, Elena D, et al. Role of gut microbiota on cardio-metabolic parameters and immunity in coronary artery disease patients with and without type-2 diabetes mellitus. Frontiers in microbiology. 2017;8:1936.
8. Kim T-H, Yang P-S, Uhm J-S, Kim J-Y, Pak H-N, Lee M-H, et al. CHA2DS2-VASc score (congestive heart failure, hypertension, age≥ 75 [doubled], diabetes mellitus, prior stroke or transient ischemic attack [doubled], vascular disease, age 65–74, female) for stroke in Asian patients with atrial fibrillation: a Korean nationwide sample cohort study. Stroke. 2017;48(6):1524-30.
9. Wiersma JJ, Verberne HJ, Trip MD, Wik L, van Eck-Smit BL, Piek JJ, et al. Prevalence of myocardial ischaemia as assessed with myocardial perfusion scintigraphy in patients with diabetes mellitus type 2 and mild anginal symptoms. European journal of nuclear medicine and molecular imaging. 2006;33(12):1468-76.
10. Morales DCV, Bhavnani SP, Ahlberg AW, Pullatt RC, Katten DM, Polk DM, et al. Coronary risk equivalence of diabetes assessed by SPECT-MPI. Journal of Nuclear Cardiology. 2019;26(4):1093-102.
11. Colon CM, Marshell RL, Roth CP, Farag AA, Iskandrian AE, Hage FG. The prognostic value of myocardial perfusion imaging in patients with type 2 myocardial infarction. Journal of Nuclear Cardiology. 2019:1-10.
12. Acampa W, Assante R, Zampella E, Petretta M, Cuocolo A. Myocardial perfusion imaging for diabetes: Key points from the evidence and clinical questions to be answered. Journal of Nuclear Cardiology. 2019:1-9.
13. Gimelli A, Achenbach S, Buechel RR, Edvardsen T, Francone M, Gaemperli O, et al. Strategies for radiation dose reduction in nuclear cardiology and cardiac computed tomography imaging: a report from the European Association of Cardiovascular Imaging (EACVI), the Cardiovascular Committee of European Association of Nuclear Medicine (EANM), and the European Society of Cardiovascular Radiology (ESCR). European heart journal. 2018;39(4):286-96.
14. Oki GCR, Pavin EJ, Coelho OR, Parisi MCR, Almeida RC, Etchebehere ECSdC, et al. Myocardial perfusion scintigraphy in the detection of silent ischemia in asymptomatic diabetic patients. Radiologia Brasileira. 2013;46(1):7-14.
15. Cohn PF, Fox KM, of WtA, Daly C. Silent myocardial ischemia. Circulation. 2003;108(10):1263-77.
16. Prior JO, Monbaron D, Koehli M, Calcagni M-L, Ruiz J, Delaloye AB. Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy. European journal of nuclear medicine and molecular imaging. 2005;32(1):60-9.
17. Yamasaki Y, Nakajima K, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R, et al. Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation. Diabetes Care. 2010;33(11):2320-6.
18. Scholte AJ, Schuijf JD, Kharagjitsingh AV, Dibbets-Schneider P, Stokkel MP, van der Wall EE, et al. Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus. European journal of nuclear medicine and molecular imaging. 2009;36(4):567-75.
19. Kawasaki-Ogita Y, Hamamoto Y, Honjo S, Ikeda H, Wada Y, Nomura K, et al. The limited usefulness of the treadmill test or a risk-guided approach in screening for asymptomatic coronary heart disease in Japanese patients with type 2 diabetes. Internal Medicine. 2012;51(24):3337-42.
20. Prior JO. Myocardial Perfusion Scintigraphy in Diabetes: Current Status and Limitations. Integrating Cardiology for Nuclear Medicine Physicians: Springer; 2009. p. 305-23.
21. Cosson E, Attali J, Valensi P. Markers for silent myocardial ischemia in diabetes. Are they helpful? Diabetes & metabolism. 2005;31(2):205-13.
22. Al-Humaidi G, Sarikaya I, Elgazzar AH, Owunwanne A. Myocardial perfusion abnormalities in asymptomatic type 2 diabetic patients. Journal of the Saudi Heart Association. 2018;30(1):3-8.
23. Mohagheghie A, Ahmadabadi M, Hedayat D, Pourbehi M, Assadi M. Myocardial perfusion imaging using technetium-99m sestamibi in asymptomatic diabetic patients. Nuklearmedizin. 2011;50(01):3-8.
24. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Archives of internal medicine. 2011;171(5):404-10.
25. Resl M, Vila G, Heinzl M, Luger A, Neuhold S, Prager R, et al. Cardiovascular risk prediction in diabetes–changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus. 2020.
26. Fox CS, Sullivan L, D’Agostino RB, Wilson PW. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes care. 2004;27(3):704-8.
27. Wu Y-T, Chien C-L, Wang S-Y, Yang W-S, Wu Y-W. Gender differences in myocardial perfusion defect in asymptomatic postmenopausal women and men with and without diabetes mellitus. Journal of Women’s Health. 2013;22(5):439-44.
28. Salehi Y, Fard-Esfahani A, Fallahi B, Aghahosseini F, Beiki D, Emami-Ardekani A, et al. The myocardial perfusion scintigraphy in asymptomatic diabetic patients. Iranian Journal of Nuclear Medicine. 2015;23(1):27-35.
29. Malik D, Mittal B, Sood A, Parmar M, Kaur G, Bahl A. Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI. Journal of Nuclear Cardiology. 2019;26(5):1650-8.